Activation of epidermal growth factor receptor results in Snail protein but not mRNA overexpression in endometrial cancer

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3858-3867

  Hipp, Susanne ^a   Walch, Axel ^b   Schuster, Tibor ^a   Losko, Sascha ^c   Laux, Holger ^d   Bolton, T ^d   Höfler, Heinz ^a,b   Becker, Karl Friedrich ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Biomax Informatics AG   (Germany)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

E cadherin; EGFR; Endometrial carcinoma; Her2; Protein microarray; Snail

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; BIOSYNTHESIS; CLUSTER ANALYSIS; DNA MICROARRAY; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHOSPHORYLATION; PILOT STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CLUSTER ANALYSIS; ENDOMETRIAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PILOT PROJECTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

GASTROPODA;

EID: 77449112393     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00526.x     Document Type: Article

References (44)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999, 49:33-64.
2. Amant F, Moerman P, Neven P. Endometrial cancer. Lancet. 2005, 366:491-505.
3. Jemal A, Murray T, Ward E. Cancer statistics, 2005. CA Cancer J Clin. 2005, 55:10-30.
4. Holcomb K, Delatorre R, Pedemonte B. E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium. Obstet Gynecol. 2002, 100:1290-5.
5. Sakuragi N, Nishiya M, Ikeda K. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol. 1994, 53:183-9.
6. Becker KF, Atkinson MJ, Reich U. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994, 54:3845-52.
7. Berx G, Becker KF, Hofler H. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998, 12:226-37.
8. Machado JC, Oliveira C, Carvalho R. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001, 20:1525-8.
9. Grady WM, Willis J, Guilford PJ. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000, 26:16-7.
10. Liu FS. Molecular carcinogenesis of endometrial cancer. Taiwan J Obstet Gynecol. 2007, 46:26-32.
11. Rashid MG, Sanda MG, Vallorosi CJ. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Cancer Res. 2001, 61:489-92.
12. Batlle E, Sancho E, Franci C. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000, 2:84-9.
13. Cano A, Perez-Moreno MA, Rodrigo I. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000, 2:76-83.
14. Hemavathy K, Ashraf SI, Ip YT. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene. 2000, 257:1-12.
15. Zhou BP, Deng J, Xia W. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004, 6:931-40.
16. Yang Z, Rayala S, Nguyen D. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res. 2005, 65:3179-84.
17. Schlessinger K, Hall A. GSK-3beta sets Snail's pace. Nat Cell Biol. 2004, 6:913-5.
18. Blechschmidt K, Kremmer E, Hollweck R. The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas. Diagn Mol Pathol. 2007, 16:222-8.
19. Yoshida H, Broaddus R, Cheng W. Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial-mesenchymal transition. Cancer Res. 2006, 66:889-97.
20. Lo HW, Hsu SC, Xia W. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 2007, 67:9066-76.
21. Yamane K, Asano Y, Tamaki K. Epidermal growth factor up-regulates transforming growth factor-beta receptor type II in human dermal fibroblasts via p38 mitogen-activated protein kinase pathway. Biochem Biophys Res Commun. 2007, 352:69-77.
22. Hackel PO, Zwick E, Prenzel N. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol. 1999, 11:184-9.
23. Lu Z, Ghosh S, Wang Z. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell. 2003, 4:499-515.
24. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005, 24:7443-54.
25. Rosivatz E, Becker I, Specht K. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002, 161:1881-91.
26. Specht K, Richter T, Muller U. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol. 2001, 158:419-29.
27. Becker KF, Schott C, Hipp S. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol. 2007, 211:370-8.
28. Eisen MB, Spellman PT, Brown PO. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95:14863-8.
29. Becker KF, Rosivatz E, Blechschmidt K. Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs. 2007, 185:204-12.
30. Hipp S, Walch A, Schuster T. Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays. Clin Exp Metastasis. 2008, 25:679-83.
31. Fujita N, Jaye DL, Kajita M. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 2003, 113:207-19.
32. Park SH, Cheung LW, Wong AS. Estrogen regulates Snail and Slug in the downregulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol. 2008, 22:2085-98.
33. Gulmann C, Sheehan KM, Kay EW. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. J Pathol. 2006, 208:595-606.
34. Shannon W, Culverhouse R, Duncan J. Analyzing microarray data using cluster analysis. Pharmacogenomics. 2003, 4:41-52.
35. Zohn IE, Li Y, Skolnik EY, Anderson KV. p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell. 2006, 125:957-69.
36. Vidyasagar A, Reese S, Acun Z. HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis. Am J Physiol Renal Physiol. 2008, 295:F707-16.
37. Barbera MJ, Puig I, Dominguez D. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene. 2004, 23:7345-54.
38. Sundberg-Smith LJ, Doherty JT, Mack CP. Adhesion stimulates direct PAK1/ERK2 association and leads to ERK-dependent PAK1 Thr212 phosphorylation. J Biol Chem. 2005, 280:2055-64.
39. Julien S, Puig I, Caretti E. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene. 2007, 26:7445-56.
40. Saegusa M, Hashimura M, Kuwata T. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells. J Pathol. 2007, 213:35-45.
41. Rolitsky CD, Theil KS, McGaughy VR. HER-2/neu amplification and overexpression in endometrial carcinoma. Int J Gynecol Pathol. 1999, 18:138-43.
42. Treeck O, Diedrich K, Ortmann O. The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrial adenocarcinoma cell lines. Eur J Cancer. 2003, 39:1302-9.
43. Bourguignon LY, Gilad E, Peyrollier K. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem. 2007, 282:19426-41.
44. Rosivatz E, Becker KF, Kremmer E. Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch. 2006, 448:277-87.